| Fund ID | 805-6980425183 |
| Fund type | Hedge Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 12% |
| Owned by funds of funds | 3% |
| Owned by non-U.S. persons | 19% |
| Fund | Type | Gross assets |
|---|---|---|
| Biotechnology Value Fund II, L.P. | Hedge | $2.32B |
| Biotechnology Value Trading Fund Os LP | Hedge | $275.6M |
| Bvf Investments, LLC | Hedge | $1.2M |
Biotechnology Value Fund, LP reports $3 billion in gross assets, among the top 2% of private funds by size.
The stated minimum investment is $25 million.
Biotechnology Value Fund, LP is managed by Bvf Partners L.P.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.